announced today that newly published data from a multicenter, prospective trial show that sacral nerve stimulation using Medtronic InterStim® Therapy reduced incontinent episodes and increased quality ...
Certain healthcare conditions often go unspoken, leading to silent struggles that affect the lives of many. Overactive bladder (OAB) and fecal incontinence (FI) are two such conditions, impacting ...
Medtronic continues to up its game in sacral neuromodulation. FDA approved InterStim X, the next generation of the company's InterStim portfolio's recharge-free device. Medtronic said implants have ...
Medtronic Inc. said Friday that it has received Food and Drug Administration approval for an implantable device to help patients better control their bowel movements. The product, called InterStim ...
Medtronic plc today announced it received approval from the U.S. Food and Drug Administration (FDA) for InterStim X™ ― the next generation of the InterStim™ portfolio’s recharge-free device – and it ...
He said nearly half of people with bowel control problems end up in nursing homes. Most patients develop fecal incontinence in their 60s and 70s, and the condition is more prevalent among women than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results